Basic Information
Epic Bio is a biotechnology company primarily focused on gene editing, dedicated to developing therapies for dynamically controlling gene expression and treating complex diseases. The company's mission is to develop a new class of genetic medicines that act on the epigenome. The epigenome is a naturally occurring mechanism that determines which genes are expressed and at what levels. Epic has developed the GEMS (Gene Expression Modulation System) platform for precise modification of gene expression. GEMS includes the largest known library of novel modulators, combined with advanced functional and computational genomics capabilities, enabling the rapid design of guide RNAs with high specificity for targeted genes.
Epicrispr Biotechnologies, Inc.
California,United States of America
15~50 people
--
info@epic-bio.com

